Table 1.
Patient characteristics
| Characteristic | Patient | |
|---|---|---|
| N | % | |
| Male | 63 | 67 |
| Median Age (Range) | 66 | |
| (30–86) | ||
| Progression | 26 | 36 |
| Tumor type: | ||
| Adenocarcinoma | 40 | 42.5 |
| Squamous cell carcinoma | 42 | 44.7 |
| Other type* | 12 | 12.8 |
| Tumor differentiation: | ||
| Well differentiated | 6 | 10.4 |
| Less differentiated | 30 | 51.7 |
| Little differentiated | 14 | 24.1 |
| Poorly differentiated | 8 | 13.8 |
| NSCLC stage: | ||
| I | 53 | 57.6 |
| II | 28 | 30.4 |
| III | 10 | 10.9 |
| IV | 1 | 1.1 |
| Lymph node metastasis | 14 | 15.2 |
*This group includes 2 large cell carcinoma patients, 10 patients with mixed tumor types (for instance adenocarcinoma/bronchioloalveolar carcinoma)